Link to the published paper, "Cooperative Orthogonal Macromolecular Assemblies with Broad Spectrum Antiviral Activity, High Selectivity, and Resistance Mitigation", by Koji Ichiyama, et al.:
<a href="http://pubs.acs.org/doi/abs/10.1021/acs.macromol.6b00091" rel="nofollow">http://pubs.acs.org/doi/abs/10.1021/acs.macromol.6b00091</a><p>Popular Science seems to represent the original article:
<a href="http://www.popsci.com/macromolecule-developed-by-ibm-could-fight-multiple-viruses-at-once" rel="nofollow">http://www.popsci.com/macromolecule-developed-by-ibm-could-f...</a><p>Summary:
"Instead, the researchers focused on glycoproteins, which sit on the outside of all viruses and attach to cells in the body, allowing the viruses to do their dirty work by infecting cells and making us sick. Using that knowledge, the researchers created a macromolecule, which is basically one giant molecule made of smaller subunits. This macromolecule has key factors that are crucial in fighting viruses. First, it’s able to attract viruses towards itself using electrostatic charges. Once the virus is close, the macromolecule attaches to the virus and makes the virus unable to attach to healthy cells. Then it neutralizes the virus’ acidity levels, which makes it less able to replicate."